Simplex Trading’s Lantern Pharma LTRN Stock Holding History

Simplex Trading’s Portfolio LTRN Stock Details LTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.5K	Buy	600 +500	+500%	+$1.47K	﹤0.01%	8549
2026 Q1	$137	Sell	100 -200	-67%	-$559	﹤0.01%	8858
2025 Q4	$909	Buy	+300	New	+$1.12K	﹤0.01%	8050
2024 Q2	–	Sell	-1,100	Closed	-$9K	–	9372
2024 Q1	$9K	Buy	+1,100	New	+$5.88K	﹤0.01%	7684
2022 Q4	–	Sell	-15,900	Closed	-$76K	–	9881
2022 Q3	$76K	Buy	15,900 +13,700	+623%	+$73.6K	﹤0.01%	5888
2022 Q2	$12K	Hold	2,200	–	–	﹤0.01%	8129
2022 Q1	$15K	Hold	2,200	–	–	﹤0.01%	8527
2021 Q4	$17K	Buy	+2,200	New	+$20.1K	﹤0.01%	8552

Other funds holding LTRN

EAM

Empery Asset Management New York $86.5M AUM

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Simplex Trading's LTRN Position: Q2 2026 in Review

Simplex Trading increased its Lantern Pharma (LTRN) stake by 2,084% in Q2 2026, buying an estimated $6.54K and bringing the position to 2,337 shares worth $9.74K. The position accounts for ﹤0.01% of the portfolio, ranked #7710.

Simplex Trading first reported a position in LTRN in Q1 2022 and has held it in 10 quarters since. The position peaked at $25K in Q1 2024. 39 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

Simplex Trading held 2,337 shares of Lantern Pharma worth $9.74K as of Q2 2026.
Simplex Trading bought 2,230 Lantern Pharma shares in Q2 2026, an estimated $6.54K.
Lantern Pharma made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7710 holding.
Simplex Trading first reported a position in Lantern Pharma in Q1 2022 and has held it in 10 quarters since.
Simplex Trading's Lantern Pharma position peaked at $25K in Q1 2024.
39 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.